- Home
- PULM vs QCLS Comparison
PULM vs QCLS Comparison
Compare PULM & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PULM | QCLS |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 4.4M |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PULM | QCLS |
|---|---|---|
| Price | $1.42 | $0.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.5K | ★ 1.3M |
| Earning Date | 11-03-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.18 | 22.33 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,910,000.00 | $3,929,527.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $67.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5069.93 | 32.71 |
| 52 Week Low | $1.16 | $0.42 |
| 52 Week High | $4.98 | $10.44 |
Technical Indicators
Market Signals| Indicator | PULM | QCLS |
|---|---|---|
| Relative Strength Index (RSI) | 44.79 | 28.92 |
| Support Level | $1.21 | $0.42 |
| Resistance Level | $1.46 | $1.18 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 21.41 | 20.15 |
Price Performance
Historical ComparisonAbout PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About QCLS Q/C Technologies Inc.
Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.